Wall Street Zen downgrades DaVita stock to Hold
Published on 10/01/2026 at 12:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DaVita stock (ISIN US23804L1035) was trading at EUR 246.00 at Lang & Schwarz on October 1, 2026 at 12:03 p.m. CEST, up 1.34 percent versus the EUR 242.75 prior close. Wall Street Zen downgraded DaVita from Buy to Hold, as MarketBeat reported on September 26, 2026.
Q2 revenue reached USD 3.55 billion
DaVita's second-quarter 2026 results give the downgrade a measurable earnings backdrop. According to StockTitan, revenue reached USD 3.554 billion for the quarter ended June 30, 2026, up 5.20 percent from the prior-year quarter. Diluted earnings per share came to USD 4.02, exceeding the USD 3.88 consensus by USD 0.14.
The operating picture was mixed rather than uniformly positive. Operating margin improved to 16.30 percent from 14.10 percent in the prior quarter, while operating cash flow reached USD 490.0 million in the second quarter of 2026, according to StockTitan.
Guidance holds despite analyst caution
DaVita reaffirmed fiscal 2026 adjusted earnings per share guidance of USD 14.10 to USD 15.20 and adjusted operating income guidance of USD 2.15 billion to USD 2.25 billion. The company also reported free cash flow of USD 256.0 million for the second quarter, while total debt stood at USD 10.848 billion, according to StockTitan.
The investor-relations page identifies a second-quarter 2026 earnings release dated August 4, 2026 and a value-based partnership with Humana dated August 25, 2026. It also states that DaVita served 298,500 patients at 3,266 outpatient dialysis centers as of June 30, 2026, according to DaVita.
Stock remains below its yearly high
The NYSE quote had a 52-week range of USD 101.00 to USD 247.49 and a market capitalization of USD 11.2 billion as of September 30, 2026. The Lang & Schwarz move puts the euro reference price USD-based market context alongside a 1.34 percent daily gain, while the analyst downgrade adds a clear counterweight to the stronger quarterly comparison.
DaVita stock facts
- Company: DaVita Inc.
- ISIN: US23804L1035
- Ticker: DVA
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 1, 2026, 12:03 p.m. CEST): EUR 246.00
- Change versus prior close: plus 1.34 percent
- Prior close Lang & Schwarz (September 30, 2026): EUR 242.75
- Market capitalization: USD 11.2 billion (as of September 30, 2026)
- 52-week range: USD 101.00-247.49 (as of September 30, 2026)
- Sector / Industry: Healthcare / Healthcare Providers and Services
